← Leaderboards
Tatiana V Kudryashova
University Of California At Davis
$1,266,392
Attributed
$1,266,392
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $463.1K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,266,392 · 1
By mechanism
R01$1,266,392 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California At Davis
Same institution · by research overlap
- Charles Decarli$84,485,572
- William Ellis$721,481
- Stefan Rothenburg$4,442,277
- Deepika Sankaran$324,916
Others in their field
Other Rising Stars on “Medial”
- Elizabeth Chrastil · University Of California-Irvine$4,432,057
- Susan Aaronson · University Of Maryland, College Park$3,438,010
- Wendy J Brickman · Lurie Children'S Hospital Of Chicago$2,830,024
- Joshua D. Wythe · Baylor College Of Medicine$2,673,001
- Zachariah Meadows Reagh · Washington University$2,631,670
- Kenneth G Payie · Agenebio, Inc.$2,446,400
Research focus
MedialMolecular TargetLungMalignant NeoplasmsApoptosisMolecularIn VivoLinkCell SurvivalAttenuatedCessation Of LifeAutomobile DrivingCytokinesisCell DeathAbnormal CellIn VitroCell ProliferationKnock-OutGrowthHomeodomainCentrosomeInduction Of ApoptosisInsightMolecular Targeted Therapies
Grant awards (4)
HIPK2 signaling in Pulmonary Arterial Hypertension$358,824
R01 · FY2025 · HL · contact PI
Administrative Supplement for R01HL166932$104,275
R01 · FY2025 · HL · contact PI
HIPK2 signaling in Pulmonary Arterial Hypertension$388,324
R01 · FY2024 · HL · contact PI
HIPK2 signaling in Pulmonary Arterial Hypertension$414,969
R01 · FY2023 · HL · contact PI